Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 4 hours ago
Why City of Hope Built a National Clinical Trials Platform Designed to Scale With Oncology Innovation
about 4 hours ago
City of Hope built a national trials engine to move oncology innovation...
Autobahn races toward pivotal trial after thyroid hormone mimic eases bipolar depression in ph. 2
about 9 hours ago
A stimulator of thyroid hormone receptors in the brain has successfully reduced...
As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
about 10 hours ago
Two federal lawmakers have introduced a bill seeking to apply the review...
Parabilis preps $413M IPO to fuel desmoid tumor drug into phase 3
about 11 hours ago
Parabilis Medicines is gearing up for an IPO that could eventually bring...
Innovent, fresh from $1.2B deal, posts phase 3 win for Takeda-partnered ADC
about 12 hours ago
Innovent Biologics has reported a phase 3 victory for IBI343, boosting the...
From business strategy to CAR-T responses, for Cabaletta it’s all about ‘durability’
about 12 hours ago
In the race to turn CAR-T cell therapies against autoimmune diseases, Cabaletta...
Medline earns FDA warning letter ire for repeated toxic bacteria problems
about 13 hours ago
Medical device distribution giant Medline has been slammed for a second time...
Alnylam pens $2B deal with Inceptive to transform siRNA design with AI pioneer
about 15 hours ago
Alnylam has partnered with the person who helped put the “T” in...
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
1 day ago
In response to a planned healthcare reform initiative in Germany that would...
Managing complexity across biopharma modalities
1 day ago
SK pharmteco CEO Joerg Ahlgrimm discusses complexity, global pressure and drug development...
Unlocking Unstructured Data with AI for Optimized Protocol Development
1 day ago
In this podcast, Mike Eckrote, SVP, Strategic Solutions at Advarra, talks about...
Fierce Biotech Fundraising Tracker '26: NewLimit nabs $435M; Accro accrues $50M series C
1 day ago
The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million...